Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
Second J&J consumer drug plant under FDA scrutiny
Yahoo/AP
Mon, 07/19/10 - 06:45 pm
JNJ
FDA
recalls
Amgen gets rapid FDA review for denosumab
Yahoo/AP
Mon, 07/19/10 - 09:30 am
Amgen
FDA
Prolia
denosumab
Amgen drug gets priority review for bone cancer
Marketwatch
Sun, 07/18/10 - 07:46 am
bone cancer
Amgen
FDA
denosumab
Prolia
FDA Officials Not Sure Agency Will Approve Direct-To-Consumer Genetic Tests
Sat, 07/17/10 - 03:55 pm
FDA
genetic testing
Vivus tanks, Arena rallies on FDA diet-drug vote
Marketwatch
Fri, 07/16/10 - 10:05 am
Vivus
Arena Pharmaceuticals
FDA
Orexigen
Contrave
Qnexa
Warner Chilcott says FDA extends drug review
Yahoo/AP
Fri, 07/16/10 - 09:46 am
FDA
Warner Chilcott
Actonel
FDA takes a closer look at possible cancer risks of widely used blood pressure medicines
Star Ledger, NJ
Fri, 07/16/10 - 09:26 am
FDA
cancer
ARBs
Merck
Cozaar
Bristol-Myers Squibb
Avapro
Atacand
Benicar
Diovan
Micardis
Teveten
Roche's Avastin Not as Good in New Studies as Early Data Showed, FDA Says
Bloomberg
Fri, 07/16/10 - 08:23 am
FDA
Avastin
Roche
breast cancer
Vivus: What Happens Next?
TheStreet.com
Fri, 07/16/10 - 08:21 am
Vivus
Qnexa
obesity
Contrave
Arena Pharmaceuticals
Orexigen
FDA
FDA Panel Rejects Vivus’s Qnexa, Citing Safety Worries
WSJ Online
Thu, 07/15/10 - 06:04 pm
FDA
obesity
Vivus
Qnexa
advisory panels
Orexigen
Arena Pharmaceuticals
Contrave
Glaxo gains on FDA panel vote for Avandia
Marketwatch
Thu, 07/15/10 - 06:01 pm
GSK
Avandia
FDA
advisory panels
Medical device industry defends federal approval process
Thu, 07/15/10 - 12:02 pm
Advanced Medical Technology Association
FDA
Arena rallies on FDA optimism; Vivus shares halted
Marketwatch
Thu, 07/15/10 - 11:17 am
FDA
advisory panels
Qnexa
Arena Pharmaceuticals
Vivus
With Avandia Now a Zombie, Can an FDA Safety Trial Survive Night of the Living Dead?
BNET Pharma
Thu, 07/15/10 - 09:38 am
FDA
advisory panels
Avandia
GSK
Glaxo Plans $2.36 Billion Charge for Legal Issues
NY Times, NY
Thu, 07/15/10 - 09:31 am
GSK
legal
Avandia
FDA
diabetes
Live Blog--Vivus' FDA Advisory Panel
TheStreet.com
Thu, 07/15/10 - 09:10 am
Vivus
Orexigen
obesity
FDA
Arena Pharmaceuticals
advisory panels
Qnexa
What The Avandia Vote Means
Forbes
Thu, 07/15/10 - 08:49 am
Avandia
GSK
advisory panels
FDA
diabetes
The Death Of Avandia
Forbes
Thu, 07/15/10 - 08:46 am
GSK
Avandia
diabetes
FDA
advisory panels
How the FDA Panel’s Votes on Avandia Votes Went Down
WSJ Online
Wed, 07/14/10 - 04:33 pm
FDA
Avandia
diabetes
GSK
advisory panels
FDA panel backs GSK's Avandia on market: reports
Marketwatch
Wed, 07/14/10 - 04:27 pm
FDA
GSK
Avandia
diabetes
advisory panels
Pages
« first
‹ previous
…
481
482
483
484
485
486
487
488
489
…
next ›
last »